<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>VNN2 &#8211; Science</title>
	<atom:link href="https://scienmag.com/tag/vnn2/feed/" rel="self" type="application/rss+xml" />
	<link>https://scienmag.com</link>
	<description></description>
	<lastBuildDate>Tue, 27 Oct 2026 12:09:40 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://scienmag.com/wp-content/uploads/2024/07/cropped-scienmag_ico-32x32.jpg</url>
	<title>VNN2 &#8211; Science</title>
	<link>https://scienmag.com</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">73899611</site>	<item>
		<title>Presarcopenia in older adults flags higher osteoporosis risk in UK Biobank study</title>
		<link>https://scienmag.com/presarcopenia-in-older-adults-flags-higher-osteoporosis-risk-in-uk-biobank-study/</link>
		
		<dc:creator><![CDATA[Beatrice Stafford]]></dc:creator>
		<pubDate>Tue, 27 Oct 2026 12:09:40 +0000</pubDate>
				<category><![CDATA[Medicine]]></category>
		<category><![CDATA[aging-related muscle and bone decline]]></category>
		<category><![CDATA[body composition]]></category>
		<category><![CDATA[body composition phenotypes]]></category>
		<category><![CDATA[bone mineral density]]></category>
		<category><![CDATA[circulating proteins and skeletal health]]></category>
		<category><![CDATA[Cohort study]]></category>
		<category><![CDATA[epidemiology of sarcopenia and obesity]]></category>
		<category><![CDATA[handgrip strength]]></category>
		<category><![CDATA[hazard ratios in osteoporosis research]]></category>
		<category><![CDATA[IGFBP7]]></category>
		<category><![CDATA[IL-18R1]]></category>
		<category><![CDATA[insulin-like growth factor-binding protein 7]]></category>
		<category><![CDATA[interleukin-18 receptor 1]]></category>
		<category><![CDATA[long-term follow-up in geriatric studies]]></category>
		<category><![CDATA[muscle loss and bone health]]></category>
		<category><![CDATA[osteoporosis]]></category>
		<category><![CDATA[presarcopenia]]></category>
		<category><![CDATA[Presarcopenia and osteoporosis risk in older adults]]></category>
		<category><![CDATA[proteomic biomarkers in aging]]></category>
		<category><![CDATA[Proteomics]]></category>
		<category><![CDATA[sarcopenia]]></category>
		<category><![CDATA[UK Biobank]]></category>
		<category><![CDATA[UK Biobank osteoporosis study]]></category>
		<category><![CDATA[vanin-2]]></category>
		<category><![CDATA[VNN2]]></category>
		<guid isPermaLink="false">https://scienmag.com/?p=352172</guid>

					<description><![CDATA[A prospective UK Biobank study finds that older adults with presarcopenic phenotypes show a suggestively higher risk of incident osteoporosis, with three circulating proteins flagged as hypothesis-generating links between muscle and bone decline.]]></description>
										<content:encoded><![CDATA[<p> The study, published in BMC Geriatrics, classified participants into four body-composition phenotypes at baseline and tracked who went on to receive an osteoporosis diagnosis over an average of 6.3 years of follow-up.</p>
<p> The categories were Normal (2,882 participants), Obese (9,393), PreSarc (634), and PreSarc-Obese (1,670). </p>
<p>Over 92,431.5 person-years of prospective follow-up, the presarcopenic phenotype was suggestively associated with a higher risk of incident osteoporosis, with a hazard ratio of 1.87 and a 95 percent confidence interval of 1.00 to 3.48, yielding a p-value of 0.049. The confidence interval touching 1.00 and the borderline p-value mean the association should be interpreted cautiously, and the authors themselves describe it as suggestive rather than definitive.</p>
<p>Obesity alone, by contrast, was not significantly associated with osteoporosis risk in this cohort. The hazard ratio for the Obese group was 0.79, with a 95 percent confidence interval of 0.53 to 1.18 and a p-value of 0.251. </p>
<p>Beyond the epidemiological cohort, the study included a proteomic component. In a subset of 196 participants, the researchers profiled circulating proteins and identified three that showed consistent negative associations with both muscle-related traits and bone mineral density: interleukin-18 receptor 1 (IL-18R1), insulin-like growth factor-binding protein 7 (IGFBP7), and vanin-2 (VNN2). In other words, higher circulating levels of these proteins were linked to lower measures of both muscle and bone health.</p>
<p>IL-18R1 was the most specifically quantified of the three. It was negatively associated with muscle mass, with a beta coefficient of -0.403 and a p-value below 0.001, and negatively associated with bone mineral density, with a beta of -0.050 and a p-value below 0.05. These are observational associations from a proteomic subset, not proof of a causal relationship.</p>
<p> In mice fed a high-fat diet, the three candidate proteins were upregulated in parallel with lower normalized grip strength and reduced trabecular bone volume fraction, with p-values below 0.01. This parallelism in the mouse model is consistent with the human proteomic findings, but it remains a model observation and does not establish that the proteins drive bone loss in humans.</p>
<p> Preliminary in silico molecular docking generated a hypothesis-generating structural model predicting a putative IL-18R1/RANKL interface stabilized by a salt bridge at a distance of 2.8 angstroms. The authors are explicit that this is a predicted structural model; direct physical binding kinetics and causal signaling cascades have not been demonstrated and require rigorous biochemical and functional validation.</p>
<p>Taken together, the findings position presarcopenic phenotypes as prospective predictors of incident osteoporosis in older adults, while the circulating proteins IL-18R1, IGFBP7, and VNN2 are offered as complementary, hypothesis-generating biological clues linking integrated muscle and bone deterioration. The authors caution that further validation is needed before these proteins can be considered causal mediators or clinical targets. </p>
<p><strong>Subject of Research:</strong> The association of presarcopenic body-composition phenotypes with incident osteoporosis risk in older UK Biobank adults, with proteomic markers of muscle and bone deterioration.</p>
<p><strong>Article Title:</strong> Association of presarcopenic phenotypes with incident osteoporosis: a prospective UK biobank cohort and proteomic study</p>
<p><strong>Article References:</strong> Xia, D., Zhai, L., Gong, W., Kou, Y., Cao, G., Bao, Y., Li, Z., Zhang, X., Gao, T., &amp; Dai, S. (2026). Association of presarcopenic phenotypes with incident osteoporosis: a prospective UK biobank cohort and proteomic study. <em>BMC Geriatrics</em>. <a href="https://doi.org/10.1186/s12877-026-08570-9" rel="noopener noreferrer">https://doi.org/10.1186/s12877-026-08570-9</a></p>
<p><strong>Image Credits:</strong> AI Generated</p>
<p><strong>DOI:</strong> <a href="https://doi.org/10.1186/s12877-026-08570-9" rel="noopener noreferrer">10.1186/s12877-026-08570-9</a></p>
<p><strong>Keywords:</strong> osteoporosis, presarcopenia, sarcopenia, UK Biobank, body composition, handgrip strength, IL-18R1, IGFBP7, VNN2, proteomics, bone mineral density, cohort study</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">352172</post-id>	</item>
	</channel>
</rss>
